Very low CD3, CD4, and CD8 cell counts indirectly support the need to decrease doses of immunosuppressive agents in patients with COVID-19, especially in those who have received antithymocyte globulin, which decreases all T-cell subsets for many weeks [69,70]. This evidence concerns the gene CD8A and COVID-19.